Chemed Corporation CHE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.57% | 8.80% | 1.63% | -0.10% | 3.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.57% | 8.80% | 1.63% | -0.10% | 3.09% |
| Cost of Revenue | 7.72% | 4.07% | 2.61% | 2.04% | 7.31% |
| Gross Profit | 16.62% | 19.91% | -0.30% | -3.82% | -4.87% |
| SG&A Expenses | 5.38% | 14.83% | 8.27% | -1.39% | 3.72% |
| Depreciation & Amortization | 7.19% | 4.46% | 5.34% | 3.15% | 3.42% |
| Other Operating Expenses | -- | 200.00% | -115.69% | 21.88% | -- |
| Total Operating Expenses | 7.26% | 6.05% | 3.76% | 1.41% | 6.44% |
| Operating Income | 33.88% | 31.02% | -10.74% | -7.05% | -15.64% |
| Income Before Tax | 15.76% | 28.42% | -7.14% | -12.22% | -17.31% |
| Income Tax Expenses | 29.80% | 26.87% | -5.77% | -3.72% | -23.55% |
| Earnings from Continuing Operations | 11.54% | 28.98% | -7.60% | -15.02% | -15.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.54% | 28.98% | -7.60% | -15.02% | -15.23% |
| EBIT | 33.88% | 31.02% | -10.74% | -7.05% | -15.64% |
| EBITDA | 29.27% | 25.90% | -8.42% | -6.01% | -12.86% |
| EPS Basic | 22.95% | 42.85% | -1.20% | -9.81% | -11.51% |
| Normalized Basic EPS | 32.95% | 42.24% | -0.71% | -2.24% | -10.58% |
| EPS Diluted | 22.20% | 43.70% | -0.41% | -9.09% | -10.80% |
| Normalized Diluted EPS | 32.31% | 43.06% | 0.14% | -1.44% | -9.83% |
| Average Basic Shares Outstanding | -9.28% | -9.71% | -6.48% | -5.78% | -4.20% |
| Average Diluted Shares Outstanding | -8.84% | -10.23% | -7.27% | -6.55% | -5.00% |
| Dividend Per Share | 16.67% | 20.00% | 20.00% | 20.00% | 20.00% |
| Payout Ratio | -0.05% | -0.15% | 0.21% | 0.33% | 0.36% |